- Home
- TECH vs CAVA Comparison
TECH vs CAVA Comparison
Compare TECH & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CAVA
- Stock Information
- Founded
- TECH 1976
- CAVA 2006
- Country
- TECH United States
- CAVA United States
- Employees
- TECH N/A
- CAVA N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CAVA Restaurants
- Sector
- TECH Health Care
- CAVA Consumer Discretionary
- Exchange
- TECH Nasdaq
- CAVA Nasdaq
- Market Cap
- TECH 12.5B
- CAVA 13.9B
- IPO Year
- TECH 1989
- CAVA 2023
- Fundamental
- Price
- TECH $74.78
- CAVA $126.56
- Analyst Decision
- TECH Buy
- CAVA Buy
- Analyst Count
- TECH 9
- CAVA 14
- Target Price
- TECH $80.67
- CAVA $112.92
- AVG Volume (30 Days)
- TECH 860.3K
- CAVA 2.6M
- Earning Date
- TECH 10-29-2024
- CAVA 11-05-2024
- Dividend Yield
- TECH 0.43%
- CAVA N/A
- EPS Growth
- TECH N/A
- CAVA N/A
- EPS
- TECH 1.05
- CAVA 0.38
- Revenue
- TECH $1,159,060,000.00
- CAVA $845,224,000.00
- Revenue This Year
- TECH $6.90
- CAVA $30.90
- Revenue Next Year
- TECH $9.69
- CAVA $20.98
- P/E Ratio
- TECH $71.22
- CAVA $339.61
- Revenue Growth
- TECH 1.97
- CAVA 31.01
- 52 Week Low
- TECH $51.79
- CAVA $29.66
- 52 Week High
- TECH $85.57
- CAVA $131.82
- Technical
- Relative Strength Index (RSI)
- TECH 47.19
- CAVA 63.50
- Support Level
- TECH $73.89
- CAVA $118.62
- Resistance Level
- TECH $80.12
- CAVA $125.66
- Average True Range (ATR)
- TECH 2.52
- CAVA 3.90
- MACD
- TECH -0.25
- CAVA -1.12
- Stochastic Oscillator
- TECH 12.61
- CAVA 60.15
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.